Evidence map›Paper›PMID 35572059›Full record

ArticleApplied bionics and biomechanics2022

Related Factors and a Threshold of the Maximum Neuron-Specific Enolase Value Affecting the Prognosis of Patients with Aneurysmal Subarachnoid Hemorrhage.

Hao Zhao, Feng Shang, Meng Qi, Yueqiao Xu, Ning Wang, Xin Qu

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Applied bionics and biomechanics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hao ZhaoDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0002-1541-8579
Feng ShangDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0002-2604-6512
Meng QiDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0001-7411-0059
Yueqiao XuDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0003-0996-9216
Ning WangDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0002-8315-881X
Xin QuDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0001-7638-7166
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prognosis of patients with subarachnoid hemorrhage is influenced by many factors. Neuron-specific enolase (NSE) is a biological marker of neurological damage. This study aimed to determine the related prognostic factors and whether or not the maximum NSE value (NSE Methods: A total of 259 patients admitted following aSAH were treated by appropriate methods. Initial neurological severity was evaluated by using the initial Glasgow coma scale and Hunt-Hess grades. NSE plasma concentration was measured during the patient's stay in the neurosurgical intensive care unit, and NSE Results: A poor outcome of patients with aSAH at discharge was associated with mild hypothermia treatment, Hunt-Hess grade, rehemorrhagia, neurogenic pulmonary edema, and pneumonia, which were independent risk factors affecting the prognosis of patients. The best threshold of the maximum value of NSE for poor or good prognosis was 26.255 Conclusions: Poor neurological score, pulmonary complications, aneurysm rerupture, and mild hypothermia indicate a poor prognosis. NSE

Identifiers

PMID35572059
PMCPMC9106454
OpenAlexW4229063704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.